首页> 外文OA文献 >Impedance method for detecting HIV-1 protease and screening for its inhibitors using ferrocene-peptide conjugate/Au nanoparticle/single-walled carbon nanotube modified electrode
【2h】

Impedance method for detecting HIV-1 protease and screening for its inhibitors using ferrocene-peptide conjugate/Au nanoparticle/single-walled carbon nanotube modified electrode

机译:二茂铁-肽结合物/ Au纳米颗粒/单壁碳纳米管修饰电极检测HIV-1蛋白酶的阻抗及其抑制剂的筛选方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A highly sensitive screening assay based on electrochemical impedance spectroscopy (EIS) has been developed for detecting HIV-1 protease (PR) and subsequent evaluation of its corresponding inhibitors at picomolar levels. The assay format was based on the immobilization of the thiol terminated ferrocene(Fc)-pepstatin conjugate on a singlewalled carbon nanotube/gold nanoparticle (SWCNT/AuNP) modified gold electrode. The alteration of the interfacial properties of electrodes upon HIV-1 PR and Fc-pepstatin conjugate interaction was traced by EIS. On the basis of the charge transfer resistance data obtained and using a mixed kinetic and diffusion model, this procedure was capable of detecting picomolar HIV-1 PR owing to the specific binding of this enzyme to Fc modified pepstatin. A competitive inhibition assay format was then performed using four potent HIV-1 PR inhibitors. The estimated inhibition constant (Ki) attested that lopinavir/ritonavir (Ki) 20 ( 3 pM) and saquinavir (Ki = 57 \ub1 8 pM) even at 10 pM competed strongly with pepstatin for effective binding to HIV-1 PR. Indinavir (Ki = 630 \ub1 22 pM) only competed well with pepstatin at a much higher concentration (1 nM). No significant inhibitory effect was observed for the fosamprenavir (Ki = 11 \ub1 0.5 nM) as expected from this pro-drug. Such results agreed well with the values reported in the literature. This assay format is a definite asset for the expedited development of effective HIV-1 PR inhibitors with low molecular weights.
机译:已经开发了一种基于电化学阻抗谱(EIS)的高灵敏度筛选测定法,用于检测HIV-1蛋白酶(PR)并随后在皮摩尔水平评估其相应的抑制剂。该测定形式基于硫醇封端的二茂铁(Fc)-胃抑素共轭物在单壁碳纳米管/金纳米粒子(SWCNT / AuNP)修饰的金电极上的固定化。 EIS追踪了HIV-1 PR和Fc-pepstatin共轭相互作用后电极的界面性质的变化。根据获得的电荷转移阻力数据并使用混合动力学和扩散模型,由于该酶与Fc修饰的胃抑素的特异性结合,该程序能够检测皮摩尔的HIV-1 PR。然后使用四种有效的HIV-1 PR抑制剂进行竞争性抑制分析。估计的抑制常数(Ki)证明即使在10 pM时,lopinavir / ritonavir(Ki)20(3 pM)和saquinavir(Ki = 57 \ ub1 8 pM)仍能与pepstatin强烈竞争与HIV-1 PR的有效结合。茚地那韦(Ki = 630 \ ub1 22 pM)仅以更高的浓度(1 nM)与pepstatin竞争良好。如该前药所预期的那样,未观察到对磷氨苯那韦具有明显的抑制作用(Ki = 11 \ ub1 0.5 nM)。这样的结果与文献报道的值非常吻合。这种测定形式是快速开发有效的低分子量HIV-1 PR抑制剂的绝对资产。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号